Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 260

1.

L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression.

Malek N, Kanavou S, Lawton MA, Pitz V, Grosset KA, Bajaj N, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Hardy J, Williams NM, Wood N, Morris HR, Grosset DG; PRoBaND clinical consortium.

Parkinsonism Relat Disord. 2019 May 14. pii: S1353-8020(19)30243-3. doi: 10.1016/j.parkreldis.2019.05.022. [Epub ahead of print]

PMID:
31105012
2.

Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson's Disease.

Sleeman I, Lawson RA, Yarnall AJ, Duncan GW, Johnston F, Khoo TK, Burn DJ.

J Parkinsons Dis. 2019;9(2):351-359. doi: 10.3233/JPD-181535.

3.

Prevalence and duration of non-motor symptoms in prodromal Parkinson's disease.

Durcan R, Wiblin L, Lawson RA, Khoo TK, Yarnall AJ, Duncan GW, Brooks DJ, Pavese N, Burn DJ; ICICLE-PD Study Group.

Eur J Neurol. 2019 Jul;26(7):979-985. doi: 10.1111/ene.13919. Epub 2019 Mar 1.

4.

Risk of Parkinson's disease dementia related to level I MDS PD-MCI.

Hoogland J, Boel JA, de Bie RMA, Schmand BA, Geskus RB, Dalrymple-Alford JC, Marras C, Adler CH, Weintraub D, Junque C, Pedersen KF, Mollenhauer B, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ; MDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”.

Mov Disord. 2019 Mar;34(3):430-435. doi: 10.1002/mds.27617. Epub 2019 Jan 17.

PMID:
30653248
5.

Developing and validating Parkinson's disease subtypes and their motor and cognitive progression.

Lawton M, Ben-Shlomo Y, May MT, Baig F, Barber TR, Klein JC, Swallow DMA, Malek N, Grosset KA, Bajaj N, Barker RA, Williams N, Burn DJ, Foltynie T, Morris HR, Wood NW, Grosset DG, Hu MTM.

J Neurol Neurosurg Psychiatry. 2018 Dec;89(12):1279-1287. doi: 10.1136/jnnp-2018-318337. Epub 2018 Jul 25.

6.

Defining delirium in idiopathic Parkinson's disease: A systematic review.

Lawson RA, McDonald C, Burn DJ.

Parkinsonism Relat Disord. 2018 Sep 26. pii: S1353-8020(18)30421-8. doi: 10.1016/j.parkreldis.2018.09.025. [Epub ahead of print] Review.

PMID:
30279060
7.

Multimorbidity Predicts Quality of Life but not Motor Severity in Early Parkinson's Disease.

Gravell R, Duncan GW, Khoo TK, Burn DJ, Sayer AA, Barker RA, Lawson RA, Yarnall AJ.

J Parkinsons Dis. 2018;8(4):511-515. doi: 10.3233/JPD-181428.

PMID:
30248064
8.

Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests.

Hoogland J, van Wanrooij LL, Boel JA, Goldman JG, Stebbins GT, Dalrymple-Alford JC, Marras C, Adler CH, Junque C, Pedersen KF, Mollenhauer B, Zabetian CP, Eslinger PJ, Lewis SJG, Wu RM, Klein M, Rodriguez-Oroz MC, Cammisuli DM, Barone P, Biundo R, de Bie RMA, Schmand BA, Tröster AI, Burn DJ, Litvan I, Filoteo JV, Geurtsen GJ, Weintraub D; IPMDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”.

Mov Disord. 2018 Nov;33(11):1750-1759. doi: 10.1002/mds.110. Epub 2018 Sep 14.

PMID:
30216541
9.

Categorising Visual Hallucinations in Early Parkinson's Disease.

Clegg BJ, Duncan GW, Khoo TK, Barker RA, Burn DJ, Yarnall AJ, Lawson RA.

J Parkinsons Dis. 2018;8(3):447-453. doi: 10.3233/JPD-181338.

PMID:
30040741
10.

Coping with Cognitive Impairment in People with Parkinson's Disease and Their Carers: A Qualitative Study.

Lawson RA, Collerton D, Taylor JP, Burn DJ, Brittain KR.

Parkinsons Dis. 2018 Apr 8;2018:1362053. doi: 10.1155/2018/1362053. eCollection 2018.

11.

Clinical prevalence of Lewy body dementia.

Kane JPM, Surendranathan A, Bentley A, Barker SAH, Taylor JP, Thomas AJ, Allan LM, McNally RJ, James PW, McKeith IG, Burn DJ, O'Brien JT.

Alzheimers Res Ther. 2018 Feb 15;10(1):19. doi: 10.1186/s13195-018-0350-6.

12.

Features of GBA-associated Parkinson's disease at presentation in the UK Tracking Parkinson's study.

Malek N, Weil RS, Bresner C, Lawton MA, Grosset KA, Tan M, Bajaj N, Barker RA, Burn DJ, Foltynie T, Hardy J, Wood NW, Ben-Shlomo Y, Williams NW, Grosset DG, Morris HR; PRoBaND clinical consortium.

J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):702-709. doi: 10.1136/jnnp-2017-317348. Epub 2018 Jan 29.

13.

A randomized, double-blind, placebo-controlled trial of camicinal in Parkinson's disease.

Marrinan SL, Otiker T, Vasist LS, Gibson RA, Sarai BK, Barton ME, Richards DB, Hellström PM, Nyholm D, Dukes GE, Burn DJ.

Mov Disord. 2018 Feb;33(2):329-332. doi: 10.1002/mds.27259. Epub 2017 Dec 26.

14.

Poor Sleep Quality and Progression of Gait Impairment in an Incident Parkinson's Disease Cohort.

O'Dowd S, Galna B, Morris R, Lawson RA, McDonald C, Yarnall AJ, Burn DJ, Rochester L, Anderson KN.

J Parkinsons Dis. 2017;7(3):465-470. doi: 10.3233/JPD-161062.

PMID:
28671141
15.

Mild cognitive impairment as a risk factor for Parkinson's disease dementia.

Hoogland J, Boel JA, de Bie RMA, Geskus RB, Schmand BA, Dalrymple-Alford JC, Marras C, Adler CH, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ; MDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”.

Mov Disord. 2017 Jul;32(7):1056-1065. doi: 10.1002/mds.27002. Epub 2017 Jun 12.

16.

Gait Rather Than Cognition Predicts Decline in Specific Cognitive Domains in Early Parkinson's Disease.

Morris R, Lord S, Lawson RA, Coleman S, Galna B, Duncan GW, Khoo TK, Yarnall AJ, Burn DJ, Rochester L.

J Gerontol A Biol Sci Med Sci. 2017 Nov 9;72(12):1656-1662. doi: 10.1093/gerona/glx071.

17.

Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases.

Malek N, Lawton MA, Grosset KA, Bajaj N, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Hardy J, Morris HR, Williams NM, Wood N, Grosset DG; PRoBaND clinical consortium.

Parkinsonism Relat Disord. 2017 Jul;40:40-46. doi: 10.1016/j.parkreldis.2017.04.006. Epub 2017 Apr 12.

18.

Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease.

Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, Duncan GW, Mollenhauer B, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn DJ, O'Brien JT.

Neurobiol Aging. 2017 Jul;55:78-90. doi: 10.1016/j.neurobiolaging.2017.03.012. Epub 2017 Mar 16.

19.

metabolic profiling of Parkinson's disease and mild cognitive impairment.

Burté F, Houghton D, Lowes H, Pyle A, Nesbitt S, Yarnall A, Yu-Wai-Man P, Burn DJ, Santibanez-Koref M, Hudson G.

Mov Disord. 2017 Jun;32(6):927-932. doi: 10.1002/mds.26992. Epub 2017 Apr 10.

20.

Divergent functional connectivity during attentional processing in Lewy body dementia and Alzheimer's disease.

Kobeleva X, Firbank M, Peraza L, Gallagher P, Thomas A, Burn DJ, O'Brien J, Taylor JP.

Cortex. 2017 Jul;92:8-18. doi: 10.1016/j.cortex.2017.02.016. Epub 2017 Mar 18.

21.

Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease.

Rochester L, Galna B, Lord S, Yarnall AJ, Morris R, Duncan G, Khoo TK, Mollenhauer B, Burn DJ.

Neurology. 2017 Apr 18;88(16):1501-1511. doi: 10.1212/WNL.0000000000003840. Epub 2017 Mar 22. Erratum in: Neurology. 2017 Jul 4;89(1):107.

22.

Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study.

Firbank MJ, Yarnall AJ, Lawson RA, Duncan GW, Khoo TK, Petrides GS, O'Brien JT, Barker RA, Maxwell RJ, Brooks DJ, Burn DJ.

J Neurol Neurosurg Psychiatry. 2017 Apr;88(4):310-316. doi: 10.1136/jnnp-2016-313918. Epub 2016 Oct 6.

23.

Stability of mild cognitive impairment in newly diagnosed Parkinson's disease.

Lawson RA, Yarnall AJ, Duncan GW, Breen DP, Khoo TK, Williams-Gray CH, Barker RA, Burn DJ; ICICLE-PD study group.

J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):648-652. doi: 10.1136/jnnp-2016-315099. Epub 2017 Mar 1.

24.

ABN News.

Burn DJ, Lawrence J.

Pract Neurol. 2016 Dec;16(6):504. doi: 10.1136/practneurol-2016-001537. No abstract available.

PMID:
28120791
25.

Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease.

Dissanayaka NNW, Lawson RA, Yarnall AJ, Duncan GW, Breen DP, Khoo TK, Barker RA, Burn DJ; ICICLE-PD study group.

Parkinsonism Relat Disord. 2017 Mar;36:63-68. doi: 10.1016/j.parkreldis.2017.01.001. Epub 2017 Jan 4.

26.

ABN News.

Lawrence J, Burn DJ.

Pract Neurol. 2017 Jan;17(1):84. doi: 10.1136/practneurol-2016-001586. Epub 2017 Jan 17. No abstract available.

PMID:
28100718
27.

Intra- and inter-network functional alterations in Parkinson's disease with mild cognitive impairment.

Peraza LR, Nesbitt D, Lawson RA, Duncan GW, Yarnall AJ, Khoo TK, Kaiser M, Firbank MJ, O'Brien JT, Barker RA, Brooks DJ, Burn DJ, Taylor JP.

Hum Brain Mapp. 2017 Mar;38(3):1702-1715. doi: 10.1002/hbm.23499. Epub 2017 Jan 13.

PMID:
28084651
28.

Cognitive impairment in Parkinson's disease: impact on quality of life of carers.

Lawson RA, Yarnall AJ, Johnston F, Duncan GW, Khoo TK, Collerton D, Taylor JP, Burn DJ; ICICLE-PD study group.

Int J Geriatr Psychiatry. 2017 Dec;32(12):1362-1370. doi: 10.1002/gps.4623. Epub 2016 Dec 7.

29.

Autonomic Dysfunction in Early Parkinson's Disease: Results from the United Kingdom Tracking Parkinson's Study.

Malek N, Lawton MA, Grosset KA, Bajaj N, Barker RA, Burn DJ, Foltynie T, Hardy J, Morris HR, Williams NM, Ben-Shlomo Y, Wood NW, Grosset DG; PRoBaND Clinical Consortium.

Mov Disord Clin Pract. 2016 Nov 24;4(4):509-516. doi: 10.1002/mdc3.12454. eCollection 2017 Jul-Aug.

30.

Lower urinary tract symptoms in Parkinson's disease: Prevalence, aetiology and management.

McDonald C, Winge K, Burn DJ.

Parkinsonism Relat Disord. 2017 Feb;35:8-16. doi: 10.1016/j.parkreldis.2016.10.024. Epub 2016 Nov 1. Review.

PMID:
27865667
31.

Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin' Sticks test in patients with Parkinson's disease.

Lawton M, Hu MT, Baig F, Ruffmann C, Barron E, Swallow DM, Malek N, Grosset KA, Bajaj N, Barker RA, Williams N, Burn DJ, Foltynie T, Morris HR, Wood NW, May MT, Grosset DG, Ben-Shlomo Y.

Parkinsonism Relat Disord. 2016 Dec;33:96-101. doi: 10.1016/j.parkreldis.2016.09.023. Epub 2016 Sep 25.

32.

Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts.

Swallow DM, Lawton MA, Grosset KA, Malek N, Klein J, Baig F, Ruffmann C, Bajaj NP, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Morris HR, Williams N, Wood NW, Hu MT, Grosset DG.

J Neurol Neurosurg Psychiatry. 2016 Nov;87(11):1183-1190. doi: 10.1136/jnnp-2016-313642. Epub 2016 Sep 26.

33.

ABN news.

Burn DJ, Lawrence J.

Pract Neurol. 2016 Oct;16(5):424. doi: 10.1136/practneurol-2016-001496. No abstract available.

PMID:
27630259
34.

Spectrum of Movement Disorders in Mitochondrial Disorders-Reply.

Martikainen MH, Burn DJ, Turnbull DM.

JAMA Neurol. 2016 Oct 1;73(10):1254-1255. doi: 10.1001/jamaneurol.2016.2578. No abstract available.

PMID:
27479912
35.

ABN news.

Burn DJ, Lawrence J.

Pract Neurol. 2016 Aug;16(4):338. doi: 10.1136/practneurol-2016-001462. No abstract available.

PMID:
27418692
36.

Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease.

Malek N, Lawton MA, Swallow DM, Grosset KA, Marrinan SL, Bajaj N, Barker RA, Burn DJ, Hardy J, Morris HR, Williams NM, Wood N, Ben-Shlomo Y, Grosset DG; PRoBaND Clinical Consortium.

Mov Disord. 2016 Oct;31(10):1518-1526. doi: 10.1002/mds.26698.

37.

Cholinergic and perfusion brain networks in Parkinson disease dementia.

Colloby SJ, McKeith IG, Burn DJ, Wyper DJ, O'Brien JT, Taylor JP.

Neurology. 2016 Jul 12;87(2):178-85. doi: 10.1212/WNL.0000000000002839. Epub 2016 Jun 15.

38.

Short latency afferent inhibition: Effects of ageing.

Yarnall AJ, Ho BS, Eshun E, David R, Rochester L, Burn DJ, Baker MR.

Clin Neurophysiol. 2016 Jun;127(6):2410-3. doi: 10.1016/j.clinph.2016.03.014. Epub 2016 Mar 19. No abstract available.

PMID:
27178860
39.

Apomorphine: A potential modifier of amyloid deposition in Parkinson's disease?

Yarnall AJ, Lashley T, Ling H, Lees AJ, Coleman SY, O'Sullivan SS, Compta Y, Revesz T, Burn DJ.

Mov Disord. 2016 May;31(5):668-75. doi: 10.1002/mds.26422. Epub 2015 Oct 13.

PMID:
27156393
40.

Clinical, Genetic, and Radiological Features of Extrapyramidal Movement Disorders in Mitochondrial Disease.

Martikainen MH, Ng YS, Gorman GS, Alston CL, Blakely EL, Schaefer AM, Chinnery PF, Burn DJ, Taylor RW, McFarland R, Turnbull DM.

JAMA Neurol. 2016 Jun 1;73(6):668-74. doi: 10.1001/jamaneurol.2016.0355.

PMID:
27111573
41.

Cognitive decline and quality of life in incident Parkinson's disease: The role of attention.

Lawson RA, Yarnall AJ, Duncan GW, Breen DP, Khoo TK, Williams-Gray CH, Barker RA, Collerton D, Taylor JP, Burn DJ; ICICLE-PD study group.

Parkinsonism Relat Disord. 2016 Jun;27:47-53. doi: 10.1016/j.parkreldis.2016.04.009. Epub 2016 Apr 11.

42.

Orthostatic hypotension and cognitive impairment in Parkinson's disease: Causation or association?

McDonald C, Newton JL, Burn DJ.

Mov Disord. 2016 Jul;31(7):937-46. doi: 10.1002/mds.26632. Epub 2016 Apr 19. Review.

PMID:
27091624
43.

Variation in Recent Onset Parkinson's Disease: Implications for Prodromal Detection.

Swallow DM, Lawton MA, Grosset KA, Malek N, Smith CR, Bajaj NP, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Hardy J, Morris HR, Williams N, Wood NW, Grosset DG; PRoBaND Clinical Consortium.

J Parkinsons Dis. 2016 Mar 19;6(2):289-300. doi: 10.3233/JPD-150741.

44.

Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD).

Williams-Gray CH, Wijeyekoon R, Yarnall AJ, Lawson RA, Breen DP, Evans JR, Cummins GA, Duncan GW, Khoo TK, Burn DJ, Barker RA; ICICLE-PD study group.

Mov Disord. 2016 Jul;31(7):995-1003. doi: 10.1002/mds.26563. Epub 2016 Mar 21.

45.

Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease.

Breen DP, Nombela C, Vuono R, Jones PS, Fisher K, Burn DJ, Brooks DJ, Reddy AB, Rowe JB, Barker RA.

Mov Disord. 2016 Jul;31(7):1062-6. doi: 10.1002/mds.26592. Epub 2016 Mar 12.

46.

Exome sequencing in dementia with Lewy bodies.

Keogh MJ, Kurzawa-Akanbi M, Griffin H, Douroudis K, Ayers KL, Hussein RI, Hudson G, Pyle A, Cordell HJ, Attems J, McKeith IG, O'Brien JT, Burn DJ, Morris CM, Thomas AJ, Chinnery PF.

Transl Psychiatry. 2016 Feb 2;6:e728. doi: 10.1038/tp.2015.220.

47.

Neural correlates of attention-executive dysfunction in lewy body dementia and Alzheimer's disease.

Firbank M, Kobeleva X, Cherry G, Killen A, Gallagher P, Burn DJ, Thomas AJ, O'Brien JT, Taylor JP.

Hum Brain Mapp. 2016 Mar;37(3):1254-70. doi: 10.1002/hbm.23100. Epub 2015 Dec 26.

48.

Olfaction in Parkin single and compound heterozygotes in a cohort of young onset Parkinson's disease patients.

Malek N, Swallow DM, Grosset KA, Lawton MA, Smith CR, Bajaj NP, Barker RA, Ben-Shlomo Y, Bresner C, Burn DJ, Foltynie T, Morris HR, Williams N, Wood NW, Grosset DG; PRoBaND Investigators.

Acta Neurol Scand. 2016 Oct;134(4):271-6. doi: 10.1111/ane.12538. Epub 2015 Dec 1.

PMID:
26626018
49.

Depressive symptoms are associated with daytime sleepiness and subjective sleep quality in dementia with Lewy bodies.

Elder GJ, Colloby SJ, Lett DJ, O'Brien JT, Anderson KN, Burn DJ, McKeith IG, Taylor JP.

Int J Geriatr Psychiatry. 2016 Jul;31(7):765-70. doi: 10.1002/gps.4389. Epub 2015 Nov 11.

50.

Anxiety and anxious-depression in Parkinson's disease over a 4-year period: a latent transition analysis.

Landau S, Harris V, Burn DJ, Hindle JV, Hurt CS, Samuel M, Wilson KC, Brown RG.

Psychol Med. 2016 Feb;46(3):657-67. doi: 10.1017/S0033291715002196. Epub 2015 Oct 23.

Supplemental Content

Support Center